Meral Beksac MD

Hear about the management of extramedullary disease in #MultipleMyeloma by watching our recent interview from #COMy2025 with the wonderful Meral Beksac (@beksac.bsky.social‬):

👉 buff.ly/76y25XF 👈

#MMSM #Myeloma #HemOnc #BloodSky #MedSky #HemeSky #Hematology

26.05.2025 09:01 — 👍 2    🔁 1    💬 0    📌 0

Happy to share my pride for having received the 2024 service award of “Scientific and Research Council of Turkey”

20.12.2024 11:27 — 👍 1    🔁 0    💬 0    📌 0

Patients on myeloma treatment can sometimes be at risk for certain infections, like the flu. Data from a study at #ASH24 shows the benefit of multiple influenza vaccine doses to better protect patients during the flu season.

08.12.2024 00:28 — 👍 5    🔁 1    💬 0    📌 0

Results from the phase 3 CEPHEUS clinical trial show the promise of DVRd treatment as a standard frontline therapy for patients without stem cell transplant: 1) quicker time to reaching MRD negativity and 2) longer time staying MRD negative. #ASH24

08.12.2024 03:25 — 👍 5    🔁 2    💬 0    📌 0

Mount Sinai Researchers Identify Six-Gene Pattern to Predict Drug Success in Multiple Myeloma Patients

Excited to share our latest work in #MultipleMyeloma! 🧬 We uncovered a six-gene signature predicting response to venetoclax, but also revealed that 1q gain can drive resistance—and how CDK7 inhibitors might reverse it. #MyelomaResearch

30.11.2024 19:17 — 👍 12    🔁 4    💬 3    📌 0

Thanks 🙏appreciate

01.12.2024 08:19 — 👍 1    🔁 0    💬 0    📌 0

Our earlier published EBMT early relapse score is validated in an external database of five registries Worldwide within WBMT a predictive approach to functional high risk ash.confex.com/ash/2024/web...

23.11.2024 19:47 — 👍 0    🔁 0    💬 0    📌 0

I will be happy to be included as well Meral Beksac Ankara Turkey

21.11.2024 05:39 — 👍 1    🔁 0    💬 0    📌 0